Cargando…

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping

BACKGROUND: Circulating tumour cells (CTCs) are a potential cancer biomarker, but current methods of CTC analysis at single-cell resolution are limited. Here, we describe high-dimensional single-cell mass cytometry proteomic analysis of CTCs in HNSCC. METHODS: Parsortix microfluidic-enriched CTCs fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Payne, Karl, Brooks, Jill, Batis, Nikolaos, Khan, Naeem, El-Asrag, Mohammed, Nankivell, Paul, Mehanna, Hisham, Taylor, Graham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645808/ https://www.ncbi.nlm.nih.gov/pubmed/37735243 http://dx.doi.org/10.1038/s41416-023-02428-2

Ejemplares similares

Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019)

Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma
por: Payne, Karl, et al.
Publicado: (2022)

Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Payne, Karl, et al.
Publicado: (2020)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Payne, Karl, et al.
Publicado: (2021)

Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation()
por: Batis, Nikolaos, et al.
Publicado: (2021)

Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA
por: Whalley, Celina, et al.
Publicado: (2021)

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
por: Bryant, Jennifer, et al.
Publicado: (2019)

Feasibility of recruitment to an oral dysplasia trial in the United Kingdom
por: Nankivell, Paul, et al.
Publicado: (2012)

Characterising the phenotypic evolution of circulating tumour cells during treatment
por: Tsao, Simon Chang-Hao, et al.
Publicado: (2018)

CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity
por: Ffrench, B., et al.
Publicado: (2023)

Refeeding syndrome – awareness, prevention and management
por: Mehanna, Hisham, et al.
Publicado: (2009)

Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
por: Mehanna, Hisham
Publicado: (2020)

Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry
por: van Maldegem, Febe, et al.
Publicado: (2021)

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial
por: Lorenc, A., et al.
Publicado: (2022)

The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review
por: Fussey, Jonathan M., et al.
Publicado: (2018)

A systematic review of the effectiveness of patient‐initiated follow‐up after cancer
por: Dretzke, Janine, et al.
Publicado: (2023)

In Vivo Flow Cytometry of Extremely Rare Circulating Cells
por: Tan, Xuefei, et al.
Publicado: (2019)

Exploring the views of patients' and their family about patient‐initiated follow‐up in head and neck cancer: A mixed methods study
por: Lorenc, Ava, et al.
Publicado: (2022)

Cell-cycle distribution of urothelial tumour cells as measured by flow cytometry.
por: Collste, L. G., et al.
Publicado: (1979)

Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
por: Perumal, Vanathi, et al.
Publicado: (2019)

Impact of label-free technologies in head and neck cancer circulating tumour cells
por: Kulasinghe, Arutha, et al.
Publicado: (2016)

Short term ex-vivo expansion of circulating head and neck tumour cells
por: Kulasinghe, Arutha, et al.
Publicado: (2016)

Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

PD-L1 expressing circulating tumour cells in head and neck cancers
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

Application of circulating tumour cells to predict response to treatment in head and neck cancer
por: Zhang, Xi, et al.
Publicado: (2022)

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2018)

Revised Modelling of the Addition of Synchronous Chemotherapy to Radiotherapy in Squamous Cell Carcinoma of the Head and Neck—A Low α/β?
por: Best, James, et al.
Publicado: (2018)

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma
por: Escudero, Laura, et al.
Publicado: (2020)

The Application of Imaging Flow Cytometry for Characterisation and Quantification of Bacterial Phenotypes
por: Power, Ann L., et al.
Publicado: (2021)

Circulating tumour cell RNA characterisation from colorectal cancer patient blood after inertial microfluidic enrichment
por: Winter, Marnie, et al.
Publicado: (2019)

Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
por: Forster, G., et al.
Publicado: (1992)

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
por: Huang, Xiaomin, et al.
Publicado: (2023)

Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma
por: Hollows, Robert, et al.
Publicado: (2018)

Ex vivo expansion of circulating tumour cells (CTCs)
por: Mohamed, Bashir M., et al.
Publicado: (2023)

Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma
por: Winter, Stuart C, et al.
Publicado: (2009)

Role of circulating tumour cells (CTCs) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)
por: Baa, Annie Kanchan, et al.
Publicado: (2023)

Evaluation of circulating tumor cells in colorectal cancer using flow cytometry
por: Mușină, Ana-Maria, et al.
Publicado: (2021)

Characterisation of Human Tumours
por: Bazill, G. W.
Publicado: (1976)

Identification and quantitation of tumour cells in cell suspensions: a comparison of cytology and flow cytometry.
por: Perez, D. J., et al.
Publicado: (1981)

Characterisation of seven human ovarian tumour cell lines.
por: Wilson, A. P., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_lkslfh6cqhpmnn31784d3a4c77